Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to improve the scientific understanding of the cardiovascular actions of cocaine, in particular the ability of cocaine to increase blood pressure.


Clinical Trial Description

Cocaine abuse has emerged as a major cause of life-threatening cardiovascular emergencies but our understanding of the underlying mechanisms mediating the adverse effects of cocaine is far from complete. Our previous studies in cocaine-naive human subjects have demonstrated that intranasal cocaine acutely stimulates the human cardiovascular system by a novel central mechanism of action.We are currently investigating a central sympatholytic drug,dexmedetomidine, in reversing the sympathomimetic effects (increase in blood pressure, heart rate and coronary vasoconstriction) of intranasal cocaine.This drug may be a new pharmacologic agent in the treatment of acute cocaine intoxication in humans. ;


Study Design


Related Conditions & MeSH terms

  • Cocaine Induced Sympathoexciation and Vasoconstriction

NCT number NCT00338546
Study type Interventional
Source University of Texas Southwestern Medical Center
Contact
Status Withdrawn
Phase Phase 1